Cervical cancer, breast cancer
Conditions
Interventions
This is a quasi-experimental study. The study population is comprised of 1,217 female employees and dependents of Roche&apos
s employee health insurance plan. The study has only one arm: all female employees and dependents aged 25 to 74. The Sírio-Libanês Hospital Population Health team has a healthcare contract with Roche
s Healthcare program, which includes assistance from the Sírio-Libanês Population Health Digital Primary Care team, focusing on engagement in breast and cervical cancer screening. The study will analy
s impact. The study will be conducted throughout the entire period of care provided by the Sírio-Libanês Health Team to Roche employees and dependents. It should be noted that the healthcare program w
s effects will be analyzed by analyzing variables related to engagement, participant satisfaction, and self-rated health, considering the periods before and after the program&apos
s implementation. At the end of the study, data analysis, discussion, and publication will be conducted.
Sponsors
Sociedade Beneficente de Senhoras Hospital Sírio-Libanês
Produtos Roche Químicos e Farmacêuticos S.A.
Eligibility
Sex/Gender
Female
Age
25 Years to 74 Years
Inclusion criteria
Inclusion criteria: All female employees, with a current employment contract and those dependent on the medical insurance of Roche employees within the age range of 25 to 74 years old will be invited to participate in this study; female
Exclusion criteria
Exclusion criteria: Women who are undergoing treatment for breast cancer or cervical cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to achieve 100% adherence to the breast and cervical cancer screening program. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected. | — |
Countries
Brazil
Contacts
Public ContactCamila Monteiro
Hospital Sirio-Libanês
Outcome results
None listed